MYXREDLIN FDA approval date
The FDA approved MYXREDLIN on 20 Jun 2019.
- FDA approval date
- 20 Jun 2019
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as INSULIN HUMAN
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2019-06-20Day | MYXREDLIN | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "BLA208157", "applicant_as_listed_by_fda": "BAXTER HLTHCARE CORP", "brand_names": ["MYXREDLIN"], "active_ingredients": ["INSULIN HUMAN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20190620", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |